Sofgen Pharma S.A. (PROCF)
OTCMKTS · Delayed Price · Currency is USD
0.1100
+0.1089 (9,900.00%)
Mar 24, 2026, 9:57 AM EST
Sofgen Pharma Market Cap
Sofgen Pharma has a market cap or net worth of $256 million as of March 25, 2026. Its market cap has decreased by -13.07% in one year.
Market Cap
256.00M
Enterprise Value
531.51M
Revenue
373.80M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.11
Market Cap Chart
Since December 9, 2019, Sofgen Pharma's market cap has increased from 239.85M to 256.00M, an increase of 6.73%. That is a compound annual growth rate of 1.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2026 | 256.00M | 342.69% |
| Dec 31, 2025 | 57.83M | -78.10% |
| Dec 31, 2024 | 264.01M | -42.51% |
| Dec 29, 2023 | 459.19M | -22.48% |
| Dec 30, 2022 | 592.33M | -46.15% |
| Dec 31, 2021 | 1.10B | 323.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CordovaCann | 3.29M |
| WEED, Inc. | 3.24M |
| Elixxer | 3.19M |
| Bespoke Extracts | 2.98M |
| SOHM, Inc. | 2.90M |
| CannaPharmaRX | 2.68M |
| Panacea Life Sciences Holdings | 2.68M |
| Full Alliance Group | 2.46M |